Skip to main content

Table 3 Rectal cancer-related HSUVs

From: Systematic review of health state utility values for economic evaluation of colorectal cancer

Valuation methods used HSUVs reported Reference
SG Healthcare professionals; patients
Disease recurrence 0.69; 0.72
Surgical resection 0.69; 0.83
Pain and complications 0.50; 0.78
Miller [7]
EQ-5D PRT + TME 0.70-0.86
Recurrent 0.67 (local) 0.70 (distant) 0.48 (local/distant)
TME 0.63-1.0
Recurrent 0.80 (local) 0.64 (distant) 0.45 (local/distant)
Van den Brink [27]a
EQ-5D Mean EQ-5D (SD)
Baseline before TME 0.88 (0.15)
6 weeks after TME 0.85(0.18)
12 weeks after TME 0.87 (0.19)
26 weeks after TME 0.88 (0.17)
52 weeks after TME 0.86 (0.6)
Hompes [18]
  1. a Ranges of reported HSUVs
  2. HSUVs health state utility values, SD standard deviation, SG standard gamble, PRT preoperative radiotherapy, TME total mesorectal excision